|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Global Pharma Product Lifecycle Management Forecast 2006-2012
Streamlining product development processes is becoming a major priority for pharmaceutical manufacturers looking to improve their market share, and respond to growing regulatory pressure and competition. This Datamonitor model forecasts the IT opportu
Pharmaceutical Branding Strategies
Use this report to benchmark your branding strategies against those of the industry’s leaders and ensure that your company is maximizing profit by effectively building and communicating brands.
Pricing and Reimbursement Series: NICE its impact on the UK...
NICE is one of the most advanced cost effectiveness assessment bodies operating in the major pharmaceutical markets. Since it was established it has had an increasing impact on the availability of new drugs in England and Wales, but has also generated
Early-Stage Pharmaceutical Marketing Budgets
Don’t allow your product’s commercial potential to falter. Use Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch to bolster your case for larger commercial budgets and to benchmark your marketing spends in pre-clin
Pricing & Reimbursement - Seven Major Markets Update
This report focuses on the latest developments in pricing and reimbursement (P&R) in the seven major markets providing analysis of P&R controls in each market and identifying key trends shaping overall market evolution and implications for Pharma
Winning Product Launch Strategies: Maximizing sales...
A new report featuring case studies of successful product launches of several key drugs. The results of 163 new product approvals and launches conducted across the US and EU are analyzed to provide up-to-date information on trends in new drug launches
Trends in Pharmaceutical Portfolio Management
Analysis of the current trends in pharmaceutical portfolio management with a focus on the interaction between marketed and R&D portfolios, and creation of additional value through portfolio synergies within a given therapeutic area.
Patient Empowerment: empowered patients can change...
Datamonitor has identified the key trends and events that drive patient empowerment and impact the pharmaceutical industry. These range from the increased access to information via internet and the rising pressures of cost containment through to how p
Sales Force Effectiveness
Explores the key trends impacting how Pharma manages its sales forces, with a review of key strategies that companies can employ to maximize sales force effectiveness. Supported by recommendations and case study analysis
The Pharmaceutical Portfolio Management Outlook
This report presents a comprehensive overview of effective portfolio management processes, with a focus on better preparing senior management, R&D and marketing executives for integrated decision-making across the organization as a whole.
The Pharmaceutical Market Outlook To 2010
This report provides a rigorous examination of the four major issues that will shape the competitive situation. The report also constructs four alternative robust scenarios that allow you to decide the likely future outlook for your company and the st
The CNS Market Outlook to 2009
In-depth analysis of the current growth opportunities, threats, leading players and their future prospects; it will enable you to understand the most attractive market sectors and discover what will influence competitive strategy and franchise develop
Physician-Targeted Internet Promotion
This report examines the benefits of Internet-based solutions as a way of targeting physicians and overcoming declining productivity in the sales process. eDetailing could potentially reduce detailing costs and increase amount of time physicians are
The Lifestyle Drugs Outlook to 2008
This report provides a timely market update, examining leading products and pipeline prospects in seven key lifestyle drug sectors, and is supported by forecasts to 2008. Today`s R&D is influenced as much by commercial unmet needs as it is by clinical
The Pharmaceutical Sales Force Outlook
This report structures and strategies to maximize ROI and boost product uptake’ provides a detailed, timely examination of sales force structures and the factors that impact sales force return on investment (ROI).
The Pharmacoeconomics Outlook
This report examines the most commonly used pharmacoeconomic methodologies with respect to both study perspective and the range of R&D costs that can be analyzed.
The Cancer Market Outlook to 2009
This report quantifies the patient potential in different cancer sub-markets and provides benchmarks for new cancer drug development and marketing strategies; identifying key areas of unmet need and profiling the market leading products of the future.
The OTC Outlook to 2007
This report analyses the recent performance of the OTC markets in the US, Japan, Germany, the UK and France.
Market Development in Anti-virals:What is Next?
This analysis deals with 26 of the most promising pharmaceutical companies with anti-viral drugs on the market. Indication by indication is measured by number of current therapies, present sales and sales development.
Navigare Marketing Medical Research AB
Our company report database is updated both through companies own participation and BioSeeker Group’s research. Daily updates and work with Sweden’s biotech companies make these company reports the most up-to-date.
|
